Mirabegron Clinical Trials
6 recruitingDrug
Phase 22Phase 42Phase 11Phase 31
Showing 1–6 of 6 trials
Recruiting
Phase 1
The Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment With Beta3-Adrenergic Receptor Agonists
Polycystic Ovary Syndrome
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)100 enrolled1 locationNCT03049462
Recruiting
Phase 4
TReating Incontinence for Underlying Mental and Physical Health
IncontinenceUrinary IncontinenceOveractive Bladder+3 more
University of California, San Francisco270 enrolled2 locationsNCT05362292
Recruiting
Phase 2
Mechanisms for Activation of Beige Adipose Tissue in Humans
Philip Kern65 enrolled1 locationNCT04666636
Recruiting
Phase 4
Strategy for Withdrawal of Pharmacological Treatment for Urinary Incontinence in Children (StayDry)
Urinary Incontinence in Children
University of Aarhus216 enrolled5 locationsNCT06465576
Recruiting
Phase 3
Efficacy of Solifenacin, Mirabegron and Combination Therapy in Children With Daytime Urinary Incontinence (BeDry)
Urinary Incontinence in Children
University of Aarhus236 enrolled5 locationsNCT06551246
Recruiting
Phase 2
Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study
NSCLCSCLC
Zhejiang Provincial People's Hospital260 enrolled1 locationNCT06534762